𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A randomized, placebo-controlled trial of early eptifibatide for non-ST–segment elevation acute coronary syndromes

✍ Scribed by Matthew T Roe; Robert H Christenson; E.Magnus Ohman; Raymond Bahr; Francis M Fesmire; Alan Storrow; Michael Mollod; W.Frank Peacock; Jeffrey A Rosenblatt; Hongqiu Yang; Elizabeth S Fraulo; James W Hoekstra; W.Brian Gibler

Book ID
117008959
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
121 KB
Volume
146
Category
Article
ISSN
1097-6744

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Early Glycoprotein IIb/IIIa Inhibiti
The Early Glycoprotein IIb/IIIa Inhibition in Non–ST-Segment Elevation Acute Coronary Syndrome (EARLY ACS) trial: A randomized placebo-controlled trial evaluating the clinical benefits of early front-loaded eptifibatide in the treatment of patients with non–ST-segment elevation acute coronary syndrome—Study design and rationale
✍ Robert P. Giugliano; L. Kristin Newby; Robert A. Harrington; C. Michael Gibson; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 148 KB